| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 815.77B | 808.93B | 801.02B | 784.97B | 320.87B | 315.38B |
| Gross Profit | 247.10B | 232.55B | 237.06B | 231.22B | 90.15B | 88.18B |
| EBITDA | 24.70B | 24.89B | 29.94B | 31.41B | 13.61B | 13.64B |
| Net Income | 3.94B | 3.82B | 7.44B | 9.03B | 3.94B | 4.18B |
Balance Sheet | ||||||
| Total Assets | 435.36B | 411.81B | 427.70B | 431.32B | 174.97B | 181.07B |
| Cash, Cash Equivalents and Short-Term Investments | 38.48B | 26.29B | 37.18B | 31.80B | 12.50B | 13.06B |
| Total Debt | 54.36B | 69.83B | 81.05B | 88.67B | 29.39B | 30.19B |
| Total Liabilities | 215.60B | 193.77B | 211.61B | 221.93B | 79.64B | 87.15B |
| Stockholders Equity | 219.48B | 217.76B | 215.84B | 209.14B | 95.10B | 93.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -41.00M | 14.69B | 3.08B | 1.86B | 6.80B |
| Operating Cash Flow | 0.00 | 16.75B | 30.61B | 24.16B | 8.63B | 12.60B |
| Investing Cash Flow | 0.00 | -12.97B | -14.61B | -14.52B | -6.48B | -8.28B |
| Financing Cash Flow | 0.00 | -14.67B | -10.62B | -5.41B | -2.71B | -1.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥181.24B | 11.70 | ― | 2.15% | 6.30% | 27.88% | |
73 Outperform | ¥183.67B | 15.83 | 7.56% | 2.74% | 2.28% | 3.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥179.00B | 45.44 | ― | 1.45% | 1.48% | -33.32% | |
59 Neutral | ¥212.50B | 17.84 | ― | 3.01% | 18.89% | -34.43% | |
55 Neutral | ¥124.60B | 39.15 | ― | 1.79% | 8.65% | -45.94% | |
53 Neutral | ¥173.10B | 115.01 | ― | 1.81% | 30.67% | ― |
Fuji Co., Ltd. has announced its decision to transfer its 49% stake in Lady Drug Store Co., Ltd. to Tsuruha Holdings Inc. and through a share buyback by Lady. This strategic move is aimed at enhancing Fuji’s corporate value by utilizing the proceeds to support its medium-term management plan and strengthen its financial foundation. Despite the divestment, Fuji plans to maintain cooperative relations with Lady as both companies are part of the AEON group, which is expected to consolidate Tsuruha as a subsidiary. This decision comes amid increasing competition in the drugstore industry and Tsuruha’s goal to accelerate decision-making and investments by making Lady a wholly owned subsidiary.
Fuji Co., Ltd. announced the sale of its shares in AEON Kyushu Co., Ltd., participating in a secondary offering as a selling shareholder. This transaction is expected to result in an extraordinary income of 1,273 million yen, impacting the company’s consolidated financial results positively for the third quarter of the fiscal year ending February 28, 2026.
Fuji Co., Ltd. has announced its participation in the secondary offering of common shares of Aeon Kyushu Co., Ltd. by selling all its shares in the company. This decision is aimed at improving capital efficiency and strengthening Fuji’s financial base, with the impact on financial results to be disclosed after the sale price is determined.
Fuji Co., Ltd. reported its consolidated financial results for the six months ending August 31, 2025, showing a slight increase in operating revenue by 1.7% to ¥408,542 million. Despite the revenue growth, the company experienced a decline in operating and ordinary profits by 12.9% and 11.8%, respectively. The profit attributable to owners of the parent rose by 4.8% to ¥2,645 million, indicating a mixed financial performance. The equity-to-asset ratio decreased slightly from 52.9% to 50.4%, reflecting changes in the company’s financial structure. The company maintained its dividend forecast, signaling stability in shareholder returns.